Projects per year
Personal profile
Headline
ASSISTANT PROFESSOR | Hematology and Oncology
Fingerprint
Dive into the research topics where Deborah Doroshow is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Active
-
A Phase 1A/1B Study of Leflunomide for Patients with PTEN Null Solid Tumors
1/01/21 → …
Project: Research
-
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)
Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 others, Aug 2022, In: Nature Medicine. 28, 8, p. 1723 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Mitotic Checkpoints and the Role of WEE1 Inhibition in Head and Neck Squamous Cell Carcinoma
Khan, S. N., Swiecicki, P. L. & Doroshow, D. B., 1 Sep 2022, In: Cancer journal (Sudbury, Mass.). 28, 5, p. 381-386 6 p.Research output: Contribution to journal › Review article › peer-review
-
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Marron, T. U., Fiel, M. I., Hamon, P., Fiaschi, N., Kim, E., Ward, S. C., Zhao, Z., Kim, J., Kennedy, P., Gunasekaran, G., Tabrizian, P., Doroshow, D., Legg, M., Hammad, A., Magen, A., Kamphorst, A. O., Shareef, M., Gupta, N. T., Deering, R., Wang, W., & 33 others, Mar 2022, In: The Lancet Gastroenterology and Hepatology. 7, 3, p. 219-229 11 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 others, Apr 2022, In: Nature Medicine. 28, 4, p. 626-629 4 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study
Bakouny, Z., Labaki, C., Bhalla, S., Schmidt, A. L., Steinharter, J. A., Cocco, J., Tremblay, D. A., Awad, M. M., Kessler, A., Haddad, R. I., Evans, M., Busser, F., Wotman, M., Curran, C. R., Zimmerman, B. S., Bouchard, G., Jun, T., Nuzzo, P. V., Qin, Q., Hirsch, L., & 16 others, Aug 2022, In: Annals of Oncology. 33, 8, p. 836-844 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press / Media
-
Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Pembrolizumab for Advanced NSCLC and PS 2-3
21/10/22
1 item of Media coverage
Press/Media
-
Dwight Tosh, the 17th patient at St. Jude, on surviving lymphoma in 1962
16/09/22
1 item of Media coverage
Press/Media
-
-
Dave Boule confronted polycythemia vera with an accountant’s consistency
17/06/22
1 item of Media coverage
Press/Media
-
In 1998, a CML patient was out of options. Then she chanced into a treatment–Gleevec
3/06/22
1 item of Media coverage
Press/Media